Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ESP018
MIFTS: 47

Esophageal Candidiasis

Categories: Gastrointestinal diseases, Immune diseases, Infectious diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Esophageal Candidiasis

About this section

MalaCards integrated aliases for Esophageal Candidiasis:

Name: Esophageal Candidiasis 12 3 15
Candidiasis of the Esophagus 12 70
Esophageal Moniliasis 12
Candidal Esophagitis 12
Candida Esophagitis 12
Esophageal Thrush 12

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Gastrointestinal diseases Immune diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:13146
ICD9CM 34 112.84
NCIt 50 C27027
SNOMED-CT 67 20639004
ICD10 32 B37.81
UMLS 70 C0239295
Sources

Summaries for Esophageal Candidiasis

About this section
CDC : 3 Candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Candida normally lives inside the body (in places such as the mouth, throat, gut, and vagina) and on skin without causing any problems.1 Sometimes, Candida can multiply and cause an infection if the environment inside the mouth, throat, or esophagus changes in a way that encourages fungal growth. Candidiasis in the mouth and throat is also called "thrush" or oropharyngeal candidiasis. Candidiasis in the esophagus (the tube that connects the throat to the stomach) is called esophageal candidiasis or Candida esophagitis. Esophageal candidiasis is one of the most common infections in people living with HIV/AIDS

MalaCards based summary : Esophageal Candidiasis, also known as candidiasis of the esophagus, is related to oral candidiasis and laryngitis. An important gene associated with Esophageal Candidiasis is CD4 (CD4 Molecule), and among its related pathways/superpathways are Linoleic acid metabolism and Statin Pathway - Generalized, Pharmacokinetics. The drugs Caspofungin and Micafungin have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and myeloid, and related phenotypes are Reduced mammosphere formation and digestive/alimentary

Disease Ontology : 12 A candidiasis that involves fungal infection of the esophagus by Candida albicans in immunocompromised people, resulting in lesions, bleeding, painful swallowing and substernal pain.

Wikipedia : 73 Esophageal candidiasis is an opportunistic infection of the esophagus by Candida albicans. The disease... more...

Sources

Related Diseases for Esophageal Candidiasis

About this section

Diseases related to Esophageal Candidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 465)
# Related Disease Score Top Affiliating Genes
1 oral candidiasis 30.7 IL17A CLEC7A CD4 CCR6 CARD9 AIRE
2 laryngitis 30.6 ATP4A ATP12A
3 candidiasis 30.4 IL17A CYP51A1 CLEC7A CARD9 AIRE
4 fungal esophagitis 30.3 ATP4A ATP12A
5 peptic ulcer disease 30.3 CYP2C19 ATP4A ATP12A
6 esophagitis, eosinophilic, 1 30.3 CCR6 CCL26 ATP4A ATP12A
7 peptic esophagitis 30.2 CYP2C19 CCL26 ATP4A ATP12A
8 esophageal disease 30.2 CCR6 CCL26 ATP4A ATP12A
9 laryngeal disease 30.2 CCR6 ATP4A ATP12A
10 dyskinesia of esophagus 30.2 CCL26 ATP4A ATP12A
11 systemic scleroderma 29.8 IL17A CD8A CD4 CCR6
12 pernicious anemia 29.8 CCR6 ATP4A ATP12A AIRE
13 gastroesophageal reflux 29.8 CYP2C19 CCL26 ATP4A ATP12A
14 invasive aspergillosis 29.6 CYP51A1 CYP2C19 CLEC7A CCR6
15 dermatitis 29.5 IL17A CD8A CD4 CCR6
16 syphilis 29.5 IL17A CD8A CD4 CCR6
17 disease by infectious agent 29.4 IL17A CD8A CD4 CCR6
18 gastritis 29.4 IL17A CYP2C19 CCR6 ATP4A
19 bilirubin metabolic disorder 29.3 CYP3A4 CYP2C9 CYP2C19 CD8A CD4
20 dermatitis, atopic 29.3 IL17A CD8A CD4 CCR6 CCL26
21 giardiasis 29.2 IL17A CD8A CD4 ATP4A ATP12A
22 immune deficiency disease 29.1 IL17A CYP3A4 CD8A CD4 CCR6 AIRE
23 chronic mucocutaneous candidiasis 28.5 IL17A CLEC7A CD8A CD4 CCR6 CARD9
24 opportunistic mycosis 28.0 IL17A CYP51A1 CLEC7A CD8A CD4 CCR6
25 fungal infectious disease 28.0 IL17A CYP51A1 CLEC7A CD8A CD4 CCR6
26 esophagitis 10.6
27 dysphagia 10.5
28 acquired immunodeficiency syndrome 10.5
29 scabies 10.4 CD4 CCR6
30 vagus nerve disease 10.4 ATP4A ATP12A
31 suppurative lymphadenitis 10.4 CD4 CCR6
32 necrotizing gastritis 10.4 ATP4A ATP12A
33 scalp dermatosis 10.4 ATP4A ATP12A
34 hemangioma of intra-abdominal structure 10.4 ATP4A ATP12A
35 acquired gastric outlet stenosis 10.4 ATP4A ATP12A
36 lingual goiter 10.4 ATP4A ATP12A
37 displacement of cardia through esophageal hiatus 10.4 ATP4A ATP12A
38 cascade stomach 10.4 ATP4A ATP12A
39 benzylpenicillin allergy 10.4 ATP4A ATP12A
40 median arcuate ligament syndrome 10.4 ATP4A ATP12A
41 afferent loop syndrome 10.4 ATP4A ATP12A
42 cervix erosion 10.4 ATP4A ATP12A
43 herpes simplex virus keratitis 10.4 CD4 CCR6
44 splenic abscess 10.4 CD4 ATP12A
45 granulomatous gastritis 10.4 ATP4A ATP12A
46 laryngeal tuberculosis 10.4 ATP4A ATP12A
47 dieulafoy lesion 10.4 ATP4A ATP12A
48 esophagus melanoma 10.4 ATP4A ATP12A
49 cefuroxime allergy 10.4 ATP4A ATP12A
50 emphysematous cholecystitis 10.4 ATP4A ATP12A

Comorbidity relations with Esophageal Candidiasis via Phenotypic Disease Network (PDN): (show all 17)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Bronchitis
Chronic Kidney Disease Decubitus Ulcer
Deficiency Anemia Esophageal Disease
Esophagitis Familial Atrial Fibrillation
Heart Disease Iron Deficiency Anemia
Neutropenia Oral Candidiasis
Protein-Energy Malnutrition Respiratory Failure
Swallowing Disorders

Graphical network of the top 20 diseases related to Esophageal Candidiasis:



Diseases related to Esophageal Candidiasis
Sources

Symptoms & Phenotypes for Esophageal Candidiasis

About this section

GenomeRNAi Phenotypes related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.1 ATP4A CCR6 CLEC7A CYP2C9 CYP51A1 IL17A

MGI Mouse Phenotypes related to Esophageal Candidiasis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.5 AIRE ATP12A ATP4A CD4 CLEC7A CYP51A1
2 immune system MP:0005387 9.28 AIRE ATP4A CARD9 CCR6 CD4 CD8A
Sources

Drugs & Therapeutics for Esophageal Candidiasis

About this section

Drugs for Esophageal Candidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 468682 2826718
2
Micafungin Approved, Investigational Phase 3 235114-32-6 3081921 477468
3
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
4
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
5
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
6
Voriconazole Approved Phase 3 137234-62-9 71616
7 Anti-Infective Agents Phase 3
8 Antifungal Agents Phase 3
9 Cytochrome P-450 CYP3A Inhibitors Phase 3
10 Hormone Antagonists Phase 3
11 Hormones Phase 3
12 Cytochrome P-450 Enzyme Inhibitors Phase 3
13 Echinocandins Phase 1
14
Amphotericin B Approved, Investigational 1397-89-3 14956 5280965
15
Ketoconazole Approved, Investigational 65277-42-1 47576
16
Itraconazole Approved, Investigational 84625-61-6 55283
17 Antiparasitic Agents
18 Liposomal amphotericin B
19 Anti-Bacterial Agents
20 Antiprotozoal Agents
21 Amebicides
22 Pharmaceutical Solutions
23
Hydroxyitraconazole 108222

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 A Multicenter, Double-Blind, Comparative Study of MK0991 (Caspofungin) Versus Micafungin in Adult Japanese Patients With Deep-seated Candida or Aspergillus Infections Completed NCT00717860 Phase 3 caspofungin acetate;Comparator: Micafungin sodium
2 A Non-comparative, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate (MK-0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults Completed NCT00635648 Phase 3 caspofungin acetate
3 A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis Completed NCT00666185 Phase 3 Micafungin;Fluconazole
4 A Phase 3, Randomized, Double-Blind, Comparative Trial of Two Dosing Regimens of Micafungin (FK463) Versus Caspofungin for the Treatment of Esophageal Candidiasis Completed NCT00665639 Phase 3 micafungin;caspofungin
5 An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients Completed NCT00002339 Phase 3 Fluconazole
6 A Prospective, Open-label, Non-comparative Study To Assess The Safety, Tolerability And Efficacy Of Voriconazole For The Primary And Salvage Treatment Of Invasive Candidiasis, Candidemia, And Esophageal Candidiasis In Pediatric Subjects Terminated NCT01092832 Phase 3 voriconazole
7 A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Infants And Toddlers (≥4 Months TO < 24 Months Of Age) With Esophageal Candidiasis Or Other Invasive Candidiasis Completed NCT00607763 Phase 1 Micafungin (Mycamine)
8 A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Children (2-5 Years AND 6-11 Years) And Adolescents (12-16 Years) With Esophageal Candidiasis Or Other Invasive Candidiasis Completed NCT00608335 Phase 1 Micafungin
9 Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients Completed NCT00002041 Amphotericin B
10 An Open, Serial-Panel, Multiple-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of L-743,872 in Patients With Candida Esophagitis Completed NCT00005921 L-743,872
11 A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients Completed NCT00002304 Ketoconazole;Fluconazole
12 Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. Completed NCT00002132 Itraconazole;Fluconazole

Search NIH Clinical Center for Esophageal Candidiasis

Sources

Genetic Tests for Esophageal Candidiasis

About this section
Sources

Anatomical Context for Esophageal Candidiasis

About this section

MalaCards organs/tissues related to Esophageal Candidiasis:

40
Skin, Lung, Myeloid, Bone, Thymus, Liver, Bone Marrow
Sources

Publications for Esophageal Candidiasis

About this section

Articles related to Esophageal Candidiasis:

(show top 50) (show all 546)
# Title Authors PMID Year
1
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain. 61
33264211 2021
2
Clinical Characteristics and Manifestations of Fungal Esophagitis: A Single-Center Experience in South China. 61
33531895 2021
3
Upper gastrointestinal endoscopy; A study from a rural population of Sindh, Pakistan. 61
33437243 2021
4
Oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin versus no antifungal prophylaxis. 61
33387388 2021
5
Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression. 61
33725014 2021
6
Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study. 61
32798703 2020
7
Late Presenters of HIV Infection in an HIV Unit of a Tertiary University Hospital in a Rural Region of Greece. 61
32295383 2020
8
Esophageal candidiasis and its diagnosis. 61
32128197 2020
9
Prevalence of HIV-associated esophageal candidiasis in sub-Saharan Africa: a systematic review and meta-analysis. 61
32982560 2020
10
What is AIDS in the Amazon and the Guianas in the 90-90-90 era? 61
32706836 2020
11
Fungal Diseases in Taiwan-National Insurance Data and Estimation. 61
31438643 2019
12
The Burden of Serious Fungal Infections in Kyrgyzstan. 61
31331088 2019
13
Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. 61
30872104 2019
14
Variations in the Clinical Course of Patients with Herpes Simplex Virus Esophagitis Based on Immunocompetence and Presence of Underlying Esophageal Disease. 61
30725296 2019
15
Esophageal candidiasis in patients from a specialty hospital 61
31618561 2019
16
Esophageal dysmotility: An intrinsic feature of megacystis, microcolon, hypoperistalsis syndrome (MMIHS). 61
30257810 2019
17
Esophageal manometry, esophagogastroduodenoscopy, and duodenal mucosal histopathology in systemic sclerosis. 61
31276037 2019
18
Estimated Burden of Serious Fungal Infections in Ghana. 61
31083531 2019
19
Acute hemiparesis and status epilepticus following endoscopic esophageal balloon dilation: is it really a stroke? 61
30343464 2019
20
Eosinophilic esophagitis: Pathophysiology, diagnosis, and management. 61
30827775 2019
21
Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis. 61
29902649 2019
22
Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients. 61
29902648 2019
23
Diagnosis and Treatment of Esophageal Candidiasis: Current Updates. 61
31772927 2019
24
Vitamin B12 Deficiency in a Patient Presenting with Dyspnea: A Case Report. 61
31172130 2019
25
A Polyclonal Antibody to NKX3.1 Identifies Fungal Organisms From the Esophagus. 61
28777145 2019
26
Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center. 61
29702297 2019
27
Opportunistic diseases in patients with HIV infection in the intensive care unit. 61
30701809 2018
28
Role of Endoscopic Findings and Biopsies in Renal Transplant Recipients With Gastrointestinal Complications: A Tertiary Care Experience. 61
29534657 2018
29
Cytology Preparations of Formalin Fixative Aid Detection of Giardia in Duodenal Biopsy Samples: A Helpful Tool for Diagnosing Esophageal Candidiasis as Well? 61
29762142 2018
30
Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis. 61
29234969 2018
31
Pneumomediastinum as a complication of esophageal intramural pseudodiverticulosis. 61
30350535 2018
32
Estimated Burden of Serious Fungal Diseases in Serbia. 61
29941824 2018
33
Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). 61
28230661 2018
34
[Candidiasis of the esophagus caused by anterior cervical surgery: a case report]. 61
29772866 2018
35
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. 61
28791666 2018
36
Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study. 61
29977259 2018
37
Estimating the Burden of Serious Fungal Infections in Uruguay. 61
29562641 2018
38
The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia. 61
29379705 2018
39
Infectious esophagitis in the immunosuppressed: Candida and beyond. 61
31897451 2018
40
Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis. 61
29608193 2018
41
Esophageal mucosa in HIV infection: A"deeper" look at this little spoken organ. 61
28387430 2017
42
Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. 61
29132400 2017
43
Recurrent episodes of esophageal candidiasis without dysphagia post-Guillain-Barré syndrome: an unusual presentation of achalasia. 61
29038193 2017
44
The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression. 61
28439794 2017
45
Narrow-band imaging can increase the visibility of fibrin caps after bleeding of esophageal varices: a case with extensive esophageal candidiasis. 61
28500570 2017
46
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. 61
28723333 2017
47
Serious fungal infections in the Philippines. 61
28220322 2017
48
What is the clinical significance of esophagogastric junction outflow obstruction? evaluation of 60 patients at a tertiary referral center. 61
28393437 2017
49
Burden of serious fungal infections in Guatemala. 61
28243758 2017
50
Serious fungal infections in Peru. 61
28188491 2017
Sources

Variations for Esophageal Candidiasis

About this section
Sources

Expression for Esophageal Candidiasis

About this section
Search GEO for disease gene expression data for Esophageal Candidiasis.
Sources

Pathways for Esophageal Candidiasis

About this section

Pathways related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

(show all 14)
# Super pathways Score Top Affiliating Genes
1
Linoleic acid metabolism 36
Show member pathways
 11.76 CYP3A4 CYP2C9 CYP2C19
2
Statin Pathway - Generalized, Pharmacokinetics 60
Show member pathways
 11.74 CYP3A4 CYP2C9 CYP2C19
3
Clomipramine Pathway, Pharmacokinetics 60
Show member pathways
 11.71 CYP3A4 CYP2C9 CYP2C19
4
Phenytoin Pathway, Pharmacokinetics 60
Show member pathways
 11.44 CYP3A4 CYP2C9 CYP2C19
5
Codeine and Morphine Metabolism 1
Show member pathways
 11.37 CYP3A4 CYP2C9 CYP2C19
6
Androstenedione and testosterone biosynthesis and metabolism p.1 23
Show member pathways
 11.31 CYP3A4 CYP2C9 CYP2C19
7
Platelet Aggregation Inhibitor Pathway, Pharmacodynamics 60
11.25 CYP3A4 CYP2C9 CYP2C19
8
Tamoxifen metabolism 1
Show member pathways
 11.09 CYP3A4 CYP2C9 CYP2C19
9
Primary immunodeficiency 36
11.01 CD8A CD4 AIRE
10
Pazopanib Pathway, Pharmacokinetics 60
Show member pathways
 10.86 CYP3A4 CYP2C9 CYP2C19
11
Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics 60
10.84 CYP3A4 CYP2C9
12
Innate Lymphoid Cell Differentiation Pathways 64
10.83 IL17A CD8A CD4 CCR6
13
Constitutive Androstane Receptor Pathway 1
10.64 CYP3A4 CYP2C9 CYP2C19
14
Hydrocodone pathway, pharmacokinetics 60
Show member pathways
 10.52 CYP3A4 CYP2C9
Sources

GO Terms for Esophageal Candidiasis

About this section

Cellular components related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.26 IL17A CD8A CD4 CCR6
2 organelle membrane GO:0031090 8.92 CYP51A1 CYP3A4 CYP2C9 CYP2C19

Biological processes related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

(show all 20)
# Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.97 IL17A CLEC7A CD8A CD4 CARD9
2 cholesterol metabolic process GO:0008203 9.7 CYP51A1 CYP3A4 CYP2C9
3 xenobiotic metabolic process GO:0006805 9.69 CYP3A4 CYP2C9 CYP2C19
4 positive regulation of interleukin-6 production GO:0032755 9.67 IL17A CLEC7A CARD9
5 positive regulation of tumor necrosis factor production GO:0032760 9.65 IL17A CLEC7A CARD9
6 steroid metabolic process GO:0008202 9.62 CYP51A1 CYP3A4 CYP2C9 CYP2C19
7 epoxygenase P450 pathway GO:0019373 9.59 CYP2C9 CYP2C19
8 cellular sodium ion homeostasis GO:0006883 9.58 ATP4A ATP12A
9 oxidative demethylation GO:0070989 9.57 CYP3A4 CYP2C9
10 sodium ion export across plasma membrane GO:0036376 9.56 ATP4A ATP12A
11 cellular potassium ion homeostasis GO:0030007 9.55 ATP4A ATP12A
12 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.54 ATP4A ATP12A
13 T cell activation GO:0042110 9.54 CLEC7A CD8A CD4
14 omega-hydroxylase P450 pathway GO:0097267 9.46 CYP2C9 CYP2C19
15 heterocycle metabolic process GO:0046483 9.43 CYP3A4 CYP2C19
16 drug metabolic process GO:0017144 9.43 CYP3A4 CYP2C9 CYP2C19
17 immune response GO:0006955 9.43 IL17A CD8A CD4 CCR6 CCL26 AIRE
18 drug catabolic process GO:0042737 9.4 CYP3A4 CYP2C9
19 exogenous drug catabolic process GO:0042738 9.33 CYP3A4 CYP2C9 CYP2C19
20 monoterpenoid metabolic process GO:0016098 8.8 CYP3A4 CYP2C9 CYP2C19

Molecular functions related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 heme binding GO:0020037 9.78 CYP51A1 CYP3A4 CYP2C9 CYP2C19
2 iron ion binding GO:0005506 9.76 CYP51A1 CYP3A4 CYP2C9 CYP2C19
3 steroid hydroxylase activity GO:0008395 9.61 CYP3A4 CYP2C9 CYP2C19
4 arachidonic acid epoxygenase activity GO:0008392 9.55 CYP2C9 CYP2C19
5 sodium:potassium-exchanging ATPase activity GO:0005391 9.54 ATP4A ATP12A
6 potassium-transporting ATPase activity GO:0008556 9.52 ATP4A ATP12A
7 caffeine oxidase activity GO:0034875 9.51 CYP3A4 CYP2C9
8 potassium:proton exchanging ATPase activity GO:0008900 9.49 ATP4A ATP12A
9 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen GO:0016712 9.43 CYP3A4 CYP2C9 CYP2C19
10 (R)-limonene 6-monooxygenase activity GO:0052741 9.4 CYP2C9 CYP2C19
11 (S)-limonene 7-monooxygenase activity GO:0018676 9.37 CYP2C9 CYP2C19
12 aromatase activity GO:0070330 9.33 CYP3A4 CYP2C9 CYP2C19
13 (S)-limonene 6-monooxygenase activity GO:0018675 9.32 CYP2C9 CYP2C19
14 monooxygenase activity GO:0004497 9.26 CYP51A1 CYP3A4 CYP2C9 CYP2C19
15 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen GO:0016705 8.92 CYP51A1 CYP3A4 CYP2C9 CYP2C19
Sources

Sources for Esophageal Candidiasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....